SCHEMBL23743299

SCHEMBL23743299

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5cccc6ccccc56)cc4)nc(-c4cccc5c4-c4ccc6ccccc6c4C5(c4ccccc4)c4ccccc4)n3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ CA12 O43570 2/20 0.35
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ CA9 Q16790 2/20 0.35
▸ TNF P01375 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23743317 0.96 SMN1; SMN2 (0.37) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23743288 0.94 MAPT (0.39) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23743306 0.93 MAPT (0.36) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23743310 0.91 ALDH1A1 (0.34) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23743308 0.91 MAPT (0.35) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23743368 0.89 TSHR (0.34) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL22159575 0.86 SMN1; SMN2 (0.41) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL25538633 0.86 MAPT (0.37) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23743272 0.85 MAPT (0.38) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL23743292 0.85 MAPT (0.38) MAPTSMN1; SMN2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210249607-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-08-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210249607-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD2, OCIAD1, OXER1 MAPT 958/4885SMN1; SMN2 4181/4885KDM4E 4378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback